- Daewoong Pharmaceutical Co., Ltd
- produziert seit
- 02.1 E066
rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) based bone graft.
rhBMP-2 in NOVOSIS is produced from recombinant E. coli which are genetically engineered with the cDNA of human BMP-2. The high-density culture and optimized purification methods enable efficient production of rhBMP-2. The entire production process and quality of rhBMP-2 are controlled under the regulation of the pharmaceutical GMP.
Novosis consists Bone Morphogenetic Protein-2(rhBMP-2) and synthetic bone graft material(100% Hydroxyapatite), as well as sterilized syringes to provide optimum Osteoinduction, Osteoconduction with high bio-compatibility.
- High purity
The purity of DW rhBMP-2 is over 95% by reverse phase HPLC.
- Cost Effective
Exceptionally efficient production process enables higher production yield of rhBMP-2.
- Guaranteed quality and safety
The production process and quality are controlled under the regulations of the pharmaceutical GMP